Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that David Topper, ...

The Artisan Developing World Fund returned 1.98% for Q1 2025 vs. 2.93% for the MSCI Emerging Markets Index. Click here to read the full commentary.